Cargo Therapeutics Q1 2024 Adj EPS $(0.87) Beats $(1.05) Estimate
Portfolio Pulse from Benzinga Newsdesk
Cargo Therapeutics (NASDAQ:CRGX) reported Q1 2024 adjusted EPS losses of $(0.87), surpassing the analyst consensus estimate of $(1.05) by 17.14%.
May 14, 2024 | 8:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cargo Therapeutics reported better-than-expected Q1 2024 earnings, with losses per share of $(0.87) against an expected $(1.05).
Beating earnings estimates typically has a positive impact on a company's stock price in the short term as it indicates better financial health and performance than anticipated by the market. This positive surprise can lead to increased investor confidence and demand for the stock.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100